Merieux Developpement

Merieux Developpement is an investment firm that specializes in healthcare and medicine.

Established in 2009, Mérieux Développement is an evergreen fund specialized in the healthcare sector, conducting growth and venture capital investments worldwide. Mérieux Développement works alongside entrepreneurs whose products and services can bring genuine advances to the health of patients and consumers, offering them access to its industry expertise and global network. We invest in future leaders of the healthcare industry. We actively support those companies who create solutions to unmet needs and provide better access to high-value products and services through innovation. We are bringing our expertise and global network to enable outstanding entrepreneurs to disrupt and create new markets. Mérieux Développement is an affiliate of Institut Mérieux, which employs around 13,000 employees worldwide with consolidated revenues exceeding EUR 2.0 billion in 2013. Other companies owned by Institut Mérieux include bioMérieux (in vitro diagnostics), Mérieux NutriSciences (food safety and nutrition services) and Transgene (immunotherapy).